APA (7th ed.) Citation

Zhang, X., Xu, S., Wang, J., Lv, Y., Wang, N., Lai, R., . . . Guo, Z. (2022). Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer? BMC Cancer, 22(1), 1. https://doi.org/10.1186/s12885-022-10199-x

Chicago Style (17th ed.) Citation

Zhang, Xiaoyun, Shuo Xu, Jiaqi Wang, Yalei Lv, Na Wang, Ruixue Lai, Ziyue Sha, Qun Zhao, and Zhanjun Guo. "Are Anti-PD-1-associated Immune Related Adverse Events a Harbinger of Favorable Clinical Prognosis in Patients with Gastric Cancer?" BMC Cancer 22, no. 1 (2022): 1. https://doi.org/10.1186/s12885-022-10199-x.

MLA (9th ed.) Citation

Zhang, Xiaoyun, et al. "Are Anti-PD-1-associated Immune Related Adverse Events a Harbinger of Favorable Clinical Prognosis in Patients with Gastric Cancer?" BMC Cancer, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12885-022-10199-x.